title: Severe hepatitis B virus reactivation related to ibrutinib monotherapy.
authors.affiliation: Department of Hematology, Tel-Aviv Sourasky Medical Center, and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. yairh@tasmc.health.gov.il.
authors.forename: Yair
authors.identifier: http://orcid.org/0000-0002-7864-0089
authors.initials: Y
authors.lastname: Herishanu
authors.affiliation: Department of Gastroenterology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.
authors.forename: Helena
authors.initials: H
authors.lastname: Katchman
authors.affiliation: Hebrew University Medical School, Jerusalem, Israel.
authors.forename: Aaron
authors.initials: A
authors.lastname: Polliack
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D000368:Aged; D006509:Hepatitis B / Q000139:chemically induced* / Q000150:complications / Q000473:pathology / Q000821:virology*; D006515:Hepatitis B virus / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy / Q000473:pathology / Q000821:virology; D008297:Male; D010880:Piperidines; D011720:Pyrazoles / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*; D012720:Severity of Illness Index; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000225:Adenine